酸在人类的衰老过程中对红细胞膜具有保护作用
Deepika1, Tikam Chand Dakal2, Richa3
1Department of Biochemistry, Central University of Haryana, Mahendergarh, 123031 Haryana India.
Indian journal of clinical biochemistry : IJCB
|September 12, 2025
概括
埃拉基酸 (EA) 保护人类红细胞免受氧化应激和衰老. 这种抗氧化化合物使关键的膜载体正常化,并减少细胞损伤,突出其健康益处.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 老年学是一门学科.
背景情况:
- 酸 (EA) 是一种天然的抗氧化和抗炎化合物,存在于石榴和果中.
- 氧化应激显著影响红细胞 (红细胞) 膜完整性,特别是在衰老过程中.
- tert-butyl氧化物 (t-BHP) 是一种常见的药物,用于在实验模型中诱导氧化应激.
研究的目的:
- 为了研究埃拉基酸 (EA) 对人类红细胞中三甲基氧化物 (t-BHP) 诱导的氧化应激的保护作用.
- 评估EA对红细胞膜载体和不同年龄组细胞衰老指标的影响.
- 通过其调节膜运输机制,阐明EA对健康的潜在优势.
主要方法:
- 来自不同年龄组的人类红细胞使用t-BHP受到氧化应激.
- 评估了不同度EA对红细胞膜Na+/H+交换器 (NHE),Na+,K+-ATPase和Ca2+-ATPase活性的体外影响.
- 测量了蛋白质碳基含量和透脆弱性,以量化氧化损伤和细胞膜完整性.
主要成果:
- 在所有年龄组的红细胞中,t-BHP显著增加了NHE活性,并降低了Na+,K+-ATPase和Ca2+-ATPase活性.
- EA治疗显著降低了NHE活性,并以度依赖的方式恢复了Na+,K+-ATPase和Ca2+-ATPase活性.
- 此外,EA的使用还降低了蛋白质碳酸含量,降低了透性脆弱性,这表明对氧化损伤的保护.
结论:
- 埃拉基酸在人体红细胞中表现出显著的抗氧化应激保护作用.
- EA调节关键的膜载体,抵消与年龄相关的变化和氧化损伤.
- 这些发现支持EA对健康有益的优势,特别是减轻细胞衰老和氧化应激.
相关概念视频
The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Aging
613
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
613
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
198
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
198
Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229


